Indian Extract Exporters: Complete Supplier Ranking with Market Share — 292 Manufacturers (2026) — TransData Nexus

Q: Who is the largest extract supplier from India?

DABUR INDIA LIMITED is the largest extract exporter from India with a 9.0% market share and export value of $1.1M.

Q: How many extract suppliers are there in India?

There are 292 active extract exporters in India, collectively shipping $12.1M worth of extract across 2,147 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top extract suppliers from India?

The top 5 extract suppliers from India — DABUR INDIA LIMITED, LUMEN MARKETING COMPANY, TORRENT PHARMACEUTICALS LTD, PANACEA BIOTEC PHARMA LIMITED, INDIAN IMMUNOLOGICALS LIMITED — together control 34.5% of total extract export value from India.

Suresh Sormare

Extract

India Pharmaceutical Trade Intelligence

$12.1M292 Suppliers109 CountriesHS 30049099

ExportsIndia → PHILIPPINES13.7%India → UNITED ARAB9.8%

#1 Supplier: DABUR INDIA #1 Buyer: REGENCY PHARMA

Extract Suppliers from India (2026) — 292 Exporters, $12.1M Market | TransData Nexus | TransData Nexus

Who Exports Extract from India — 292 Suppliers Behind a $12.1M Market

India's extract export market is supplied by 292 active exporters who collectively shipped $12.1M across 2,147 shipments. DABUR INDIA LIMITED leads with a 9.0% market share, followed by LUMEN MARKETING COMPANY and TORRENT PHARMACEUTICALS LTD. The top 5 suppliers together control 34.5% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published April 2026·

India's Top Extract Suppliers & Exporters — 292 manufacturers, $12.1M export market, top destinations and formulations — Extract supplier data — 292 exporters · $12.1M market · 2,147 shipmentsTransData Nexus · Indian Customs Data

Top Extract Exporters from India — Ranked by Export Value

DABUR INDIA LIMITED is the leading extract exporter from India, holding a 9.0% share of the $12.1M market across 2,147 shipments from 292 exporters. The top 5 suppliers — DABUR INDIA LIMITED, LUMEN MARKETING COMPANY, TORRENT PHARMACEUTICALS LTD, PANACEA BIOTEC PHARMA LIMITED, INDIAN IMMUNOLOGICALS LIMITED — collectively control 34.5% of total export value, indicating a competitive market. Individual shares are: DABUR INDIA LIMITED (9.0%), LUMEN MARKETING COMPANY (7.7%), TORRENT PHARMACEUTICALS LTD (6.1%), PANACEA BIOTEC PHARMA LIMITED (6.0%), INDIAN IMMUNOLOGICALS LIMITED (5.8%).

Top Extract Exporters from India

Ranked by export value · 292 active suppliers · Indian Customs (DGFT) data

Apr 2026

Top Extract Exporters from India — Ranked by Export Value. 292 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1	DABUR INDIA LIMITED

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Extract exporters

Certification and compliance status for top Extract suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Torrent Pharmaceuticals Limited	Warning Letter, October 2	Yes	Yes	Not verified	Received FDA warning for CGMP violations at Indrad facility.
J.B. Chemicals & Pharmaceuticals Limited	Not verified	Yes	Yes	Not verified	Listed as WHO-GMP certified manufacturer.
Panacea Biotec Pharma Limited	Warning Letter, September	Not verified	Not verified	Not verified	Received FDA warning letter for CGMP violations.
Sun Pharmaceutical Industries Limited	Warning Letter, March 202	Not verified	Not verified	Not verified	Received FDA warning letter for CGMP violations.
Aurobindo Pharma Limited	Warning Letter, January 2	Not verified	Not verified	Not verified	Received FDA warning letter for CGMP violations.
Lupin Limited	Warning Letter, October 2	Not verified	Not verified	Not verified	Received FDA warning letter for CGMP violations.
Glenmark Pharmaceuticals Limited	Warning Letter, October 2	Not verified	Not verified	Not verified	Received FDA warning letter for CGMP violations.
Emcure Pharmaceuticals Limited	Warning Letter, August 20	Not verified	Not verified	Not verified	Received FDA warning letter for CGMP violations.
Indoco Remedies Limited	Warning Letter, July 2019	Not verified	Not verified	Not verified	Received FDA warning letter for CGMP violations.
Mylan Laboratories Limited	Warning Letter, December	Not verified	Not verified	Not verified	Received FDA warning letter for CGMP violations.

TransData Nexus reviewed the regulatory standing of 10 leading Extract exporters from India. 0 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 2 are EU GMP compliant. 9 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Extract sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal center for active pharmaceutical ingredients (APIs) and bulk drug manufacturing. The city hosts Genome Valley, India's first biotech cluster, which is home to over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories and Aurobindo Pharma. This concentration of firms, coupled with advanced R&D infrastructure and a skilled talent pool from institutions such as the National Institute of Pharmaceutical Education and Research (NIPER), positions Hyderabad as a leader in API production and innovation.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its robust pharmaceutical manufacturing ecosystem, particularly in formulations. Gujarat contributes nearly 28% of India's pharmaceutical production, with Ahmedabad and Vadodara serving as key hubs. The region is home to prominent companies such as Zydus Cadila, Torrent Pharmaceuticals, and Cadila Pharmaceuticals. The presence of these firms, along with a strong support infrastructure including ports and roads, underscores the area's significance in the pharmaceutical sector.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Extract exporters from India

November 2024

M&A

DABUR INDIA LIMITED — Dabur acquires 51% stake in Sesa Care for ₹315-325 crore

Dabur India Limited acquired a 51% stake in Sesa Care, an Indian haircare company, for an enterprise value of ₹315-325 crore. - IMPACT: This acquisition is expected to diversify Dabur's product portfolio, potentially influencing its Extract exports.

Impact: This acquisition is expected to diversify Dabur's product portfolio, potentially influencing its Extract exports.

TransData Nexus Industry Research · Regulatory filings and press releases · Mar 2026

Common Questions — Extract Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which extract supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, DABUR INDIA LIMITED leads with 126 recorded shipments worth $1.1M. LUMEN MARKETING COMPANY (10 shipments) and TORRENT PHARMACEUTICALS LTD (11 shipments) are also established high-volume exporters.

Q How many extract manufacturers are there in India?

India has 292 active extract exporters with a combined export market of $12.1M across 2,147 shipments to 109 countries. The top 5 suppliers hold 34.5% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Extract

Extract

Who Exports Extract from India — 292 Suppliers Behind a $12.1M Market

Top Extract Exporters from India — Ranked by Export Value

Top Extract Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

DABUR INDIA LIMITED — Dabur acquires 51% stake in Sesa Care for ₹315-325 crore

Common Questions — Extract Suppliers from India

Q Which extract supplier from India is the most reliable for bulk orders?

Q How many extract manufacturers are there in India?

Q What certifications should I verify?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Q What is the typical price range for extract from India?

Analysis Methodology